Author:
Francis Dileep,Yadagini Teja Karthik,Ravindran Resmi
Publisher
Springer Nature Singapore
Reference203 articles.
1. Abhithaj J, Francis D, Sharanya CS, Arun KG, Sadasivan C, Variyar EJ (2022) Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro. J Biomol Struct Dyn 40:325–336. https://doi.org/10.1080/07391102.2020.1813200
2. Adli M (2018) The CRISPR tool kit for genome editing and beyond. Nat Commun 9:1911. https://doi.org/10.1038/s41467-018-04252-2
3. Ahn NG, Wang AH-J (2008) Proteomics and genomics: perspectives on drug and target discovery. Curr Opin Chem Biol 12:1–3. https://doi.org/10.1016/j.cbpa.2008.02.016
4. Amiri-Dashatan N, Koushki M, Abbaszadeh H-A, Rostami-Nejad M, Rezaei-Tavirani M (2018) Proteomics applications in health: biomarker and drug discovery and food industry. Iran J Pharm Res 17:1523–1536
5. Arun KG, Sharanya CS, Abhithaj J, Francis D, Sadasivan C (2021) Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. J Biomol Struct Dyn 39:4647–4658. https://doi.org/10.1080/07391102.2020.1779819